Sort
30,917 grants matching “tumor microenvironment”
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
$408,718Guangyong Peng · Washington University · R01 · FY2023 · CA
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
$408,703Edgar G. Engleman · Stanford University · P01 · FY2024 · CA
Core A: Pathobiology Core
$408,681Massimo F Loda · Columbia University Health Sciences · P01 · FY2023 · CA
Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction
$408,656Arun Sreekumar · Baylor College Of Medicine · R01 · FY2019 · CA
IL13Ra2 targeted T-cell therapy for glioma
$408,625Irina V Balyasnikova · University Of Chicago · R21 · FY2014 · NS
Tumor and Stromal Metalloproteinases in Breast Cancer
$408,553Lynn M Matrisian · Vanderbilt University · R01 · FY2008 · CA
Programmable DNA Binding Oligomers for Control of Transcription
$408,538Peter B. Dervan · California Institute Of Technology · R01 · FY2017 · GM
Programmable DNA Binding Oligomers for Control of Transcription
$408,538Peter B. Dervan · California Institute Of Technology · R01 · FY2015 · GM
Programmable DNA Binding Oligomers for Control of Transcription
$408,538Peter B. Dervan · California Institute Of Technology · R01 · FY2016 · GM
Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis
$408,530Arnold I. Caplan · Case Western Reserve University · R01 · FY2022 · CA
Molecular Imaging of Metabolic Switches in Malignant Transformations
$408,526Heather Christofk · California Institute Of Technology · U54 · FY2011 · CA
Initiation and Evolution of the Ovarian Cancer Microenvironment
$408,500Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
Initiation and Evolution of the Ovarian Cancer Microenvironment
$408,500Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Non-genomic resistance mechanisms in EGFR-mutant lung cancer
$408,487Aaron N Hata · Massachusetts General Hospital · R01 · FY2022 · CA
Regulation of CD8+T cells by Zbtb42
$408,469Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2024 · CA
Programmable DNA Binding Oligomers for Control of Transcription
$408,426Peter B. Dervan · California Institute Of Technology · R01 · FY2014 · GM
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$408,425Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2023 · AG
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$408,401Melanie R Rutkowski · University Of Virginia · R01 · FY2022 · CA
Crosstalk between glioma cells & immune cells in the tumor microenvironment: Ther
$408,374Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2011 · NS
Developing a Translation Pipeline for VHL Mutant Malignancies
$408,334David McDermott · Beth Israel Deaconess Medical Center · U01 · FY2021 · CA
Role of the pro-inflammatory omental microenvironment in ovarian cancer progression
$408,231Chi Lam Au Yeung · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Regulation of Angpt1 and DIPG blood-brain barrier integrity by H3K27M mutations
$408,149Timothy N Phoenix · University Of Cincinnati · R01 · FY2023 · NS
Project 1: Evolution of transcriptional programs in lung cancer progression
$408,138Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2019 · CA
A Regulatory Triad: IL35, Tregs and iTr35
$408,100Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
Breast Cancer Targeting Peptides for Improved Efficacy of Current Cancer Treatment
$408,074Kamaljit Kaur · Chapman University · R15 · FY2017 · CA